Search
Amphotericin B
go.drugbank.com/drugs/DB00681ApprovedInvestigationalAmphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mu...
Products: AMPHOLIP Injection 50mg/10ml, AMPHOTRET FOR INJECTION USP 50MGAvelumab
go.drugbank.com/drugs/DB11945ApprovedInvestigational[A261496] On September 18 and December 18 of the same year, it was also granted approval by EMA [L48126] and Health Canada,[L48171] respectively. … [A261496] Avelumab was first approved by the FDA on March 23, 2017.
Products: BAVENCIO CONCENTRATE FOR SOLUTION FOR INFUSION 200MG/10ML, BAVENCIO 200 mg/10mL concentrate for solution for infusionOseltamivir
go.drugbank.com/drugs/DB00198ApprovedInvestigationalThe authors concluded that oseltamivir use in healthy adults had small, non-specific effects on symptoms (where the time to first alleviation of symptoms was only reduced from 7 to 6.3 days), it had no … effect on hospitalizations, and that there was no evidence for any reductions in complications of influenza such as pneumonia.
Products: Tamiflu capsule 30mg, Tamiflu Capsule 30mgRavulizumab
go.drugbank.com/drugs/DB11580ApprovedInvestigational[A244465] It was later approved by the European Commission on July 2, 2019, for the same indications.[L39710] Ravulizumab is also used to treat myasthenia gravis. … It is a humanized monoclonal IgG2/4 kappa antibody produced in Chinese hamster ovary (CHO) cells.
Products: ULTOMIRIS ® RAVULIZUMAB 100MG/ML., Ultomiris 100mg/mL Concentrate For Solution For InfusionCinacalcet
go.drugbank.com/drugs/DB01012ApprovedInvestigationalIt is used to treat hyperparathyroidism due to parathyroid tumours or renal failure. … Cinacalcet is a calcimimetic sold by Amgen under the trade name Sensipar® in North America and Australia and as Mimpara® in Europe.
Products: CALCELAR 25mg Film Coated Tablet, PMS-cinacalcetErenumab
go.drugbank.com/drugs/DB14039ApprovedInvestigationalIt is composed of 2 heavy chains, each containing 456 amino acids, and 2 light chains of the lambda subclass, each containing 216 amino acids, with an approximate molecular weight of 150 kDa [FDA Label … Aimovig, as released and marketed by Novartis and Amgen, is in fact a novel therapeutic approach as the first and only FDA approved treatment specifically developed to prevent migraine by blocking the
Products: PASURTA® 70MG/ML, AIMOVIG SOLUTION FOR INJECTION IN PRE-FILLED PEN 140MG/MLMefloquine
go.drugbank.com/drugs/DB00358ApprovedIt was approved by the FDA in 1989, and was first marketed by Hoffman Laroche. … Individuals at the highest risk for malaria are those in disease naïve populations, children under age 5, refugees in Central and Eastern Africa, nonimmune civilian and military travelers, pregnant women
Products: Lariam Tab 250mgCefadroxil
go.drugbank.com/drugs/DB01140ApprovedInvestigationalVet approvedWithdrawnLong-acting, broad-spectrum, water-soluble, cephalexin derivative.
Products: CEFADROXILO 250MG/5ML, SOFIDROX CAPSULE 250MGLidocaine
go.drugbank.com/drugs/DB00281ApprovedInvestigationalVet approvedIt is even included in the World Health Organization's List of Essential Medicines [L6055]. … As a result, lidocaine is also considered a class Ib anti-arrhythmic agent [L5930, L5948, F4468].
Mixtures: easyangin Mentholgeschmack 5mg/1mg Lutschtabletten, LIDOFAST 40MG/2ML+0,025MG/2ML ENJEKSIYONLUK COZELTI ICEREN AMPUL, 20 ADETCategories: Antihistamines, Anesthetics, Etc.Ceritinib
go.drugbank.com/drugs/DB09063ApprovedInvestigationalThe FDA approved ceritinib in April 2014 due to a surprisingly high response rate (56%) towards crizotinib-resistant tumours and has designated it with orphan drug status. … This occurrence led to development of novel second-generation ALK inhibitors such as ceritinib to overcome crizotinib resistance.
Products: ZYKADIA CAPSULE 150mg, Zykadia 150mg Hard Capsules